AVRO

AVROBIO (AVRO)

AVROBIO Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AVRO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AVRO	AVROBIO Inc
2024/05/06	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AVRO	AVROBIO Inc
2024/02/28	00 : 50	PR Newswire (US)	Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm	NASDAQ:AVRO	AVROBIO Inc
2024/02/24	06 : 00	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AVRO	AVROBIO Inc
2024/02/06	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVRO	AVROBIO Inc
2024/02/06	09 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVRO	AVROBIO Inc
2024/02/06	09 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVRO	AVROBIO Inc
2024/02/06	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVRO	AVROBIO Inc
2024/02/02	04 : 25	PR Newswire (US)	Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm	NASDAQ:AVRO	AVROBIO Inc
2024/01/31	06 : 47	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:AVRO	AVROBIO Inc
2024/01/31	06 : 07	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:AVRO	AVROBIO Inc
2024/01/31	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVRO	AVROBIO Inc
2024/01/30	23 : 05	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:AVRO	AVROBIO Inc
2024/01/30	22 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVRO	AVROBIO Inc
2024/01/30	22 : 00	Business Wire	AVROBIO and Tectonic Therapeutic Announce Merger	NASDAQ:AVRO	AVROBIO Inc
2023/11/10	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AVRO	AVROBIO Inc
2023/11/04	05 : 15	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:AVRO	AVROBIO Inc
2023/08/11	05 : 32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AVRO	AVROBIO Inc
2023/07/12	20 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVRO	AVROBIO Inc
2023/07/12	20 : 00	Business Wire	AVROBIO to Explore Strategic Alternatives	NASDAQ:AVRO	AVROBIO Inc
2023/07/04	02 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVRO	AVROBIO Inc
2023/06/15	06 : 20	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AVRO	AVROBIO Inc
2023/06/12	20 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVRO	AVROBIO Inc
2023/06/12	20 : 00	Business Wire	AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million	NASDAQ:AVRO	AVROBIO Inc
2023/06/10	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVRO	AVROBIO Inc
2023/06/09	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRO	AVROBIO Inc
2023/06/09	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRO	AVROBIO Inc
2023/06/09	05 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRO	AVROBIO Inc
2023/06/09	05 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRO	AVROBIO Inc
2023/06/09	05 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRO	AVROBIO Inc